Hudson Biotech
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS8
PHASE 3 / 2-31
RECRUITING8
READOUTS ≤12 MONTHS8
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| MTII-VIT NCT07437560 |
P2 | Recruiting | NonSegmental Vitiligo; Nonsegmental Vitiligo (Stable) | 60 | 2027-02-14 |
| BPC-HAMSTR NCT07437547 |
P2 | Recruiting | Hamstring Muscle Strain; Skeletal Muscle Injury | 120 | 2027-02-14 |
| CuHeal NCT07437586 |
P2 | Recruiting | Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) | 60 | 2027-02-14 |
| MOTS-MET NCT07505745 |
P2 | Recruiting | Prediabetes; Insulin Resistance | 120 | 2027-02-14 |
| TBRIDGE-CV NCT07487363 |
P1/2 | Recruiting | Atherosclerotic Cardiovascular Diseases; Endothelial Dysfunction | 80 | 2027-02-14 |
| TESA-LIVER NCT07481734 |
P2 | Recruiting | Metabolic Associated Steatotic Liver Disease; Nonalcoholic Steatohepatitis | 120 | 2027-02-14 |
| SURMOUNT-1 NCT07481747 |
P3 | Recruiting | Obesity; Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities | 2539 | 2027-02-14 |
| GZBF NCT07467447 |
P2 | Recruiting | Obesity | 300 | 2027-03-14 |